GTS5:PALB2-related cancer predisposition syndrome (PALB2): Difference between revisions

[unchecked revision][unchecked revision]
No edit summary
No edit summary
Line 133: Line 133:
!Gene; Genetic Alteration!!Pathway!!Pathophysiologic Outcome
!Gene; Genetic Alteration!!Pathway!!Pathophysiologic Outcome
|-
|-
|<span class="blue-text">EXAMPLE:</span> ''BRAF'' and ''MAP2K1''; Activating mutations
|PALB2; Loss of function germline variants (frameshift, nonsense, splice site, deletions)
|<span class="blue-text">EXAMPLE:</span> MAPK signaling
|Homologous recombination (HR) DNA double-strand break repair
|<span class="blue-text">EXAMPLE:</span> Increased cell growth and proliferation
|Disruption of PALB2-mediated BRCA1–BRCA2 complex formation leads to impaired RAD51 recruitment, defective high fidelity DNA repair, homologous recombination deficiency, and genomic instability, promoting tumor initiation and progression<ref name=":0" /><ref name=":1" /><ref name=":2" />
|-
|-
|<span class="blue-text">EXAMPLE:</span> ''CDKN2A''; Inactivating mutations
|PALB2; Biallelic inactivation (germline + somatic second hit)
|<span class="blue-text">EXAMPLE:</span> Cell cycle regulation
|DNA damage response and genome stability maintenance
|<span class="blue-text">EXAMPLE:</span> Unregulated cell division
|Complete loss of PALB2 function results in profound HR deficiency (“BRCAness”), accumulation of chromosomal aberrations, and increased sensitivity to DNA-damaging agents and PARP inhibition<ref name=":2" /><ref name=":3" /><ref name=":4" /><ref name=":5" />
|-
|-
|<span class="blue-text">EXAMPLE:</span> ''KMT2C'' and ''ARID1A''; Inactivating mutations
|PALB2; Biallelic germline variants
|<span class="blue-text">EXAMPLE:</span> Histone modification, chromatin remodeling
|Fanconi anemia (FA) pathway / interstrand crosslink repair
|<span class="blue-text">EXAMPLE:</span> Abnormal gene expression program
|ailure of FA pathway coordination causes Fanconi anemia complementation group N, characterized by bone marrow failure, developmental abnormalities, and early-onset malignancies<ref name=":2" /><ref>Reid S, et al. Biallelic mutations in PALB2 cause Fanconi anemia subtype N. Nat Genet. 2007.</ref>
|-
|-
|
|PALB2; Reversion mutations (therapy-associated)
|
|Restoration of homologous recombination repair
|
|Secondary somatic mutations restore PALB2 reading frame or function, reactivating HR repair and leading to resistance to PARP inhibitors and platinum-based chemotherapy<ref name=":10" /><ref name=":11" />
|}
|}
==Genetic Diagnostic Testing Methods==
==Genetic Diagnostic Testing Methods==